So far, Arbaugh, based in Arizona, was the only patient to have received the implant, but Musk said he hopes to have participants in the high single digits this year.
The tiny wires of Neuralink’s brain chip implant used in the first participant in a trial run by Elon Musk’s company have become “more or less very stable”, a company executive said on Wednesday.
